Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NUDT15 inhibitors(nudix hydrolase 15 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18N4O5S |
InChIKeyHNCVDRFFJZJQRW-UHFFFAOYSA-N |
CAS Registry2567914-01-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | SE | 20 Jul 2020 | |
Leukemia | Preclinical | SE | 20 Jul 2020 |